{"doi":"10.1016/j.pharmthera.2017.10.009","title":"Direct antiviral agents (DAAs) - A new age in the treatment of hepatitis C virus infection","abstract":null,"journal":"Pharmacology & Therapeutics","year":2018,"id":25697,"datarank":7.490281572207967,"base_score":5.170483995038151,"endowment":5.170483995038151,"self_citation_contribution":0.7755725992557229,"citation_network_contribution":6.714708972952244,"self_endowment_contribution":0.7755725992557229,"citer_contribution":6.714708972952244,"corpus_percentile":null,"corpus_rank":null,"citation_count":175,"citer_count":175,"citers_with_citation_signal":150,"citers_with_endowment":150,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":150525,"name":"Ulrich Spengler","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":5.170483995038151,"endowment":5.170483995038151,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"29024739","pmcid":null,"openalex_id":"https://openalex.org/W2762048449","authors":[],"funders":[],"total_grants":0,"fwci":14.0032,"citation_percentile":0.99406287,"influential_citations":6,"citation_trend":[{"year":2017,"count":1},{"year":2018,"count":33},{"year":2019,"count":30},{"year":2020,"count":33},{"year":2021,"count":25},{"year":2022,"count":19},{"year":2023,"count":13},{"year":2024,"count":9},{"year":2025,"count":11},{"year":2026,"count":1}],"oa_status":"closed","license":"https://www.elsevier.com/tdm/userlicense/1.0/","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S0163725817302462?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0163725817302462?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.pharmthera.2017.10.009","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/29024739","host_type":"repository"}],"fields_of_study":["Hepatitis C virus research","Liver Disease Diagnosis and Treatment","Hepatitis B Virus Studies","Medicine","Antiviral Agents","Drug Interactions","Hepacivirus","Hepatitis C","Humans","Liver Cirrhosis","Liver Neoplasms","Protease Inhibitors","Viral Nonstructural Proteins"],"mesh_terms":["Antiviral Agents","Drug Interactions","Hepatitis C","Humans","Liver Cirrhosis","Liver Neoplasms","Protease Inhibitors","Hepacivirus","Viral Nonstructural Proteins"],"keywords":["Hepatitis C virus","Medicine","Hepatitis C","Cirrhosis","Hepatitis","Drug","Viral hepatitis","Virology","Antiviral drug","Interferon","Antiviral therapy","Hepacivirus","Combination therapy","Virus","Immunology","Pharmacology","Chronic hepatitis","Internal medicine","Hcv Therapy","Hcv Ns5a Inhibitor","Hcv Polymerase Inhibitor","Hcv Proteinase Inhibitor","Hcv Viral Resistance"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-08T07:10:43.826137Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}